SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRamsdens Hldgs Regulatory News (RFX)

Share Price Information for Ramsdens Hldgs (RFX)

Share Price is delayed by 15 minutes
Get Live Data
442.50    7.50 (1.72%)
Bid:
440.00
Ask:
445.00
Spread: 5.00 (1.136%)
Market Cap: £143.17m
RFX Live PriceLast checked at - London Stock Exchange

Intraday Ramsdens Hldgs Share Chart

Trading Update

9 Apr 2021 07:00

RNS Number : 9013U
Ramsdens Holdings PLC
09 April 2021
Β 

Ramsdens Holdings PLC

("Ramsdens" or the "Group")

Trading Update

Resilient H1 performance against challenging market conditions

Ramsdens Holdings PLC, the diversified financial services provider and retailer, announces a pre-close trading update for the six months ended 31 March 2021 (the "Period").

The Group delivered a resilient performance during the Period. The stronger restrictions imposed since we last updated the market in December 2020 significantly reduced high street footfall and the additional international travel restrictions further weakened demand for foreign currency exchange.

Against this backdrop, the Group maintained a prudent approach to controlling costs and protecting resources, whilst operating almost 90% of the Ramsdens store estate in a COVID-secure way to safeguard staff and customers. We have continued to invest in our online jewellery retail proposition, where revenue has more than doubled year on year.

As a result of these dynamics, the Board anticipates reporting a small loss for the Period but still traded cash positively.

The Group's balance sheet and liquidity remains strong with cash of approximately Β£15m at the Period end and an undrawn revolving credit facility of Β£10m.

Peter Kenyon, CEO of Ramsdens commented:

"We are pleased with the Group's resilient performance despite the ongoing difficult trading conditions - testament to the strengths of Ramsdens' diversified business model.

We are encouraged by the vaccine roll out, the expected re-opening of non-essential retail in England next week and the most recent UK Government announcements on international leisure travel as 'sticking to the road map'. Whilst the lack of current detail regarding certain country restrictions and quarantine conditions means we are unable to provide guidance for this summer's FX trading, we do believe there is significant underlying consumer demand for international summer travel which is encouraging.

Subject to no changes to the expected easing of social restrictions, we believe that our next financial year should see more normal trading patterns return and therefore anticipate opening new stores over the next six months as part of our long-term growth strategy.Β 

I would like to take this opportunity to thank the Ramsdens team for their continued dedication to serving our local communities throughout the pandemic."

Β 

Β 

Enquiries:

Ramsdens Holdings PLC Tel: +44 (0) 1642 579957

Peter Kenyon, CEO

Martin Clyburn, CFO

Β 

Liberum Capital Limited (Nominated Adviser) Tel: +44 (0) 20 3100 2000

Richard Crawley

Lauren Kettle

Β 

Hudson Sandler (Financial PR) Tel: +44 (0) 20 7796 4133

Alex Brennan

Lucy Wollam

Β 

About Ramsdens

Ramsdens is a growing, diversified, financial services provider and retailer, operating in the four core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. Ramsdens does not offer unsecured high cost short term credit.

Β 

Headquartered in Middlesbrough, the Group operates from 156 stores within the UK (including 3 franchised stores) and has a growing online presence.

Β 

Ramsdens is fully FCA authorised for its pawnbroking and credit broking activities.

Β 

www.ramsdensplc.comΒ 

www.ramsdensforcash.co.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDKFBKOBKDFQK
Date   Source Headline
3rd Jun 20267:00 amRNSInterim Results - six months ended 31 March 2026
6th May 20267:00 amRNSTrading Update
7th Apr 20262:54 pmRNSDirector/PDMR Shareholding
7th Apr 202611:54 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTrading Update
9th Mar 20263:38 pmRNSResult of AGM
9th Mar 20263:38 pmRNSResult of AGM
12th Feb 20261:45 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSNotice of AGM
14th Jan 20267:00 amRNSAnnual Results - year ended 30 September 2025
7th Jan 20267:00 amRNS-RNotice of Annual Results Investor Presentation
12th Dec 20257:00 amRNSAppointment of Nominated Adviser and Broker
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 202510:08 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
8th Oct 20257:00 amRNSPre-Close Trading Update
10th Sep 20252:17 pmRNSHolding(s) in Company
21st Aug 20259:35 amRNSHolding(s) in Company
19th Jun 202510:47 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSInterim Results - six months ended 31 March 2025
16th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
2nd May 20257:00 amRNSDirector/PDMR Shareholding
28th Apr 20252:54 pmRNSHolding(s) in Company
24th Apr 20259:47 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTrading Update
17th Mar 20254:05 pmRNSChange of Registered Office Address
14th Mar 20253:21 pmRNSDirector/PDMR Shareholding
13th Mar 202510:58 amRNSCSOP update
3rd Mar 20254:27 pmRNSResult of AGM
3rd Mar 20257:00 amRNSAGM Business Update
29th Jan 20257:00 amRNSIssue of Equity, PDMR and Total Voting Rights
23rd Jan 202512:46 pmRNSNotice of AGM
14th Jan 20257:00 amRNSAnnual Results - year ended 30 September 2024
28th Oct 20243:55 pmRNSHolding(s) in Company
11th Oct 20244:31 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSPre-Close Trading Update and Notice of Results
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTrading Update
1st Jul 20247:00 amRNSNominated Adviser and Broker
5th Jun 202411:42 amRNSHolding(s) in Company
5th Jun 20247:00 amRNSInterim Results - six months ended 31 March 2024
24th May 202410:51 amRNSHolding(s) in Company
24th May 20247:00 amRNSNotice of Interim Results Investor Presentation
23rd May 20247:00 amRNSForthcoming Board Changes
16th May 20247:00 amRNSNotice of Interim Results
14th May 202412:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.